You are here

Highly accurate small-RNA sequencing of single cells (RealSeq-SC)

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R44HG009863-02
Agency Tracking Number: R44HG009863
Amount: $2,600,409.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: 172
Solicitation Number: PA18-574
Timeline
Solicitation Year: 2018
Award Year: 2019
Award Start Date (Proposal Award Date): 2019-09-20
Award End Date (Contract End Date): 2021-06-30
Small Business Information
2161 DELAWARE AVE STE E
Santa Cruz, CA 95060-5790
United States
DUNS: 117042779
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 SERGIO BARBERANSOLER
 (831) 205-0127
 sbarberan@realseqbiosciences.com
Business Contact
 SERGIO BARBERANSOLER
Phone: (831) 205-0127
Email: sbarberan@realseqbiosciences.com
Research Institution
N/A
Abstract

Abstract
The goal of this grant application is to develop the first commercially available library preparation
kit for profiling small RNAs from single cells using NGS methods. Single-cell analyses of mRNA
have allowed the identification of crucial differences between cells that were otherwise considered
identical. These findings have shown that there is intrinsic “noise” in the regulation of gene
expression within a population of cells that plays an important role in determining cell fates.
Unfortunately, there is currently a lack of information about the cell-to-cell variability of levels of
microRNAs that as gene expression regulators may also play a critical role. Indeed, there is no
commercially available library preparation kit for miRNAs and other small RNAs that can profile
single cells. We propose to quantify miRNAs from single cells using an advanced, proprietary “low
input single adapter and circularization” technology that allows sensitive and unbiased detection.
The core single adapter and circularization technology, for higher input quantities, demonstrated
unbiased detection of over 70% of all miRNAs in a benchmark Universal miRNA pool, compared
to ~35% from the best competitor kit. We have further developed this technology for single-cell
analysis by creating a novel “low input version” that retains the detection accuracy even at single-
cell levels. Data from our Phase I studies show that this “low input adapter” minimizes dropout
events (a critical and common problem in single cell analysis) by increasing the efficiency of
miRNA detection. Another major obstacle for single-cell miRNA sequencing is formation of
adapter-dimers lacking miRNA inserts during library preparation that critically reduces the amount
of useful miRNA sequencing reads. We employ three separate strategies to dramatically reduce
the presence of adapter-dimers in the library. Also, our protocol performs all steps from cell lysis
to final purification of amplified libraries in a single tube to reduce loss of miRNA from single-cells
and to reduce the possibility of contamination of single-cell samples by environmental RNA. In
Phase I we demonstrated proof-of-principle by detecting small RNAs from single-cells for three
different cell lines. In Phase II, we will further develop and optimize our technology to significantly
increase sensitivity and detection accuracy of miRNAs and other small RNAs from single cells for
commercial viability. We will also develop a kit for single-cell small RNA-seq library preparation
(RealSeq-SC).Health relatedness narrative
Transcriptomic analysis of single cells has shown that there is a high cell-to-cell variability in gene
expression among apparently identical cells in a population. However, a similar analysis is not
currently possible for levels of small RNAs, which play key roles in regulating gene expression.
The goal of this grant application is to develop the first commercially available library preparation
kit for profiling microRNAs from single cells that enables detection of very early changes in
development of individual tumor cells and eventually could be used for early-stage cancer
diagnostics and for more effective, personalized therapeutic development.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government